prostate cancer and prostatic diseases سال:2016 - دوره:19

Fa | Ar | En


prostate cancer and prostatic diseases
سال:2016 - دوره:19 - شماره:1

A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy - صفحه:100-106 A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer - صفحه:79-83 Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2 : ERG fusion status - صفحه:53-56 Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population - صفحه:28-34 Association of diet and lifestyle with chronic prostatitis/chronic pelvic pain syndrome and pain severity: a case–control study - صفحه:92-99 Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review - صفحه:68-71 Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer - صفحه:14-20 Comparison of digit ratio (2D:4D) between Brazilian men with and without prostate cancer - صفحه:107-110 Determinants of long-term survival of patients with locally advanced prostate cancer: the role of extensive pelvic lymph node dissection - صفحه:63-67 Evaluation of an epithelial plasticity biomarker panel in men with localized prostate cancer - صفحه:40-45 Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control - صفحه:46-52 Influence of 1 year of androgen deprivation therapy on lipid and glucose metabolism and fat accumulation in Japanese patients with prostate cancer - صفحه:57-62 Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer: a single biopsy cohort analysis - صفحه:35-39 Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links - صفحه:7-13 Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts - صفحه:21-27 Prostatectomy at high-volume centers improves outcomes and lowers the costs of care for prostate cancer - صفحه:84-91 The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancer - صفحه:72-78 Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer - صفحه:1-6